Prospective, Open-label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients
NCT00262314 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 509
Last updated 2013-11-14
Summary
The overall objective of this study is to collect data relevant to the tolerability of Novantrone® therapy in patients with multiple sclerosis (MS) using dosing and monitoring recommendations specified in the package insert.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Randy Bennett · EMD Serono
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-10-31
- Primary Completion
- 2008-01-31
- Completion
- 2008-09-30
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS
NCT03799718 ·Status: COMPLETED ·Phase: PHASE2
-
Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis
NCT03996291 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
NCT05949580 ·Status: RECRUITING
-
Characterization of Early Patients Initiating Ofatumumab for Treatment of Multiple Sclerosis.
NCT05576779 ·Status: COMPLETED
-
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
NCT01081782 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)
NCT02861014 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)
NCT00304291 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis
NCT01093326 ·Status: COMPLETED ·Phase: PHASE2
-
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
NCT05269004 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis
NCT05061953 ·Status: RECRUITING
-
Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers
NCT02452996 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis
NCT01497262 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label Study of Liothyronine in MS
NCT02506751 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis
NCT00219908 ·Status: TERMINATED ·Phase: PHASE2
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
NCT02994121 ·Status: RECRUITING
-
A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
NCT01433250 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Natalizumab Safety Extension Study
NCT00276172 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Monitoring of Drugs Used in the Treatment of Multiple Sclerosis
NCT05112484 ·Status: NOT_YET_RECRUITING
-
Phase 3 Study to Evaluate Efficacy and Safety of NU100 in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
NCT01464905 ·Status: UNKNOWN ·Phase: PHASE3
-
Neural Stem Cell Transplantation in Multiple Sclerosis Patients
NCT03269071 ·Status: COMPLETED ·Phase: PHASE1
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis
NCT02219932 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis
NCT00257855 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis
NCT00529581 ·Status: COMPLETED ·Phase: PHASE2
-
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)
NCT06526364 ·Status: RECRUITING